Neurocrine Biosciences to Present at the Oppenheimer 31st Annual Healthcare Conference
SAN DIEGO, March 9, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc., (Nasdaq: NBIX) will present at the Oppenheimer 31st Annual Healthcare Conference at 4:30 p.m. Eastern Time on Tuesday Mar. 16, 2021. Matt Abernethy, Chief Financial Officer, will present at the conference.
The live presentation will be webcast and may be accessed on the Company's website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.
About Neurocrine Biosciences
View original content to download multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-oppenheimer-31st-annual-healthcare-conference-301243884.html
SOURCE Neurocrine Biosciences, Inc.
Company Codes: NASDAQ-NMS:NBIX